Flexus Biosciences, created in 2013 (United States), from 496 sister brands and 17477 competing brands. The Flexus Biosciences brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. Flexus Biosciences belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(Flexus Biosciences)
over 5 years*
USD 59.90